Xuan Marian Thai

Array ( [id] => 5785258 [patent_doc_number] => 20060204994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Novel human protein kinases and protein kinase-like enzymes' [patent_app_type] => utility [patent_app_number] => 11/367775 [patent_app_country] => US [patent_app_date] => 2006-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 54548 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20060204994.pdf [firstpage_image] =>[orig_patent_app_number] => 11367775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5068954 [patent_doc_number] => 20070190055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'CCR3 inhibition for ocular angiogenesis and macular degeneration' [patent_app_type] => utility [patent_app_number] => 11/357288 [patent_app_country] => US [patent_app_date] => 2006-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3846 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20070190055.pdf [firstpage_image] =>[orig_patent_app_number] => 11357288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4898884 [patent_doc_number] => 20080118498 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'Humanized Anti-Ghrelin Antibodies' [patent_app_type] => utility [patent_app_number] => 11/815379 [patent_app_country] => US [patent_app_date] => 2006-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13405 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20080118498.pdf [firstpage_image] =>[orig_patent_app_number] => 11815379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5693705 [patent_doc_number] => 20060153852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Novel human Jak2 kinase' [patent_app_type] => utility [patent_app_number] => 11/348405 [patent_app_country] => US [patent_app_date] => 2006-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12388 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20060153852.pdf [firstpage_image] =>[orig_patent_app_number] => 11348405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5842150 [patent_doc_number] => 20060120996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Vaccine immunotherapy for immune suppressed patients' [patent_app_type] => utility [patent_app_number] => 11/337358 [patent_app_country] => US [patent_app_date] => 2006-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15972 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20060120996.pdf [firstpage_image] =>[orig_patent_app_number] => 11337358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4785006 [patent_doc_number] => 20080138335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'Stabilized Human IgG2 And IgG3 Antibodies' [patent_app_type] => utility [patent_app_number] => 11/794950 [patent_app_country] => US [patent_app_date] => 2006-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19491 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20080138335.pdf [firstpage_image] =>[orig_patent_app_number] => 11794950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5241687 [patent_doc_number] => 20070020179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Acute leukemia and lymphoblastic lymphoma-specific CD43 epitope and use thereof' [patent_app_type] => utility [patent_app_number] => 11/312126 [patent_app_country] => US [patent_app_date] => 2005-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8164 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20070020179.pdf [firstpage_image] =>[orig_patent_app_number] => 11312126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5872936 [patent_doc_number] => 20060165686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Combining therapies targeting multiple toll-like receptors and use thereof' [patent_app_type] => utility [patent_app_number] => 11/301373 [patent_app_country] => US [patent_app_date] => 2005-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 21807 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20060165686.pdf [firstpage_image] =>[orig_patent_app_number] => 11301373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4932833 [patent_doc_number] => 20080003608 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-03 [patent_title] => 'Highly Specific Polyclonal Antibodies of Individual Core Histone and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 11/791086 [patent_app_country] => US [patent_app_date] => 2005-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 1427 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20080003608.pdf [firstpage_image] =>[orig_patent_app_number] => 11791086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5834252 [patent_doc_number] => 20060246082 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Therapeutic peptides and method' [patent_app_type] => utility [patent_app_number] => 11/284086 [patent_app_country] => US [patent_app_date] => 2005-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 19692 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20060246082.pdf [firstpage_image] =>[orig_patent_app_number] => 11284086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5367206 [patent_doc_number] => 20090304765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'R-RAS ACTIVITY IN VASCULAR REGULATION' [patent_app_type] => utility [patent_app_number] => 12/093439 [patent_app_country] => US [patent_app_date] => 2005-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 17045 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20090304765.pdf [firstpage_image] =>[orig_patent_app_number] => 12093439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5322930 [patent_doc_number] => 20090060920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'DESACYL GHRELIN ANTIBODIES AND THERAPEUTIC USES THEREOF' [patent_app_type] => utility [patent_app_number] => 11/577530 [patent_app_country] => US [patent_app_date] => 2005-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18042 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20090060920.pdf [firstpage_image] =>[orig_patent_app_number] => 11577530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4628916 [patent_doc_number] => 08007798 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-30 [patent_title] => 'Treatment of complement-associated disorders' [patent_app_type] => utility [patent_app_number] => 11/249825 [patent_app_country] => US [patent_app_date] => 2005-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 90 [patent_figures_cnt] => 107 [patent_no_of_words] => 51716 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/007/08007798.pdf [firstpage_image] =>[orig_patent_app_number] => 11249825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7502259 [patent_doc_number] => 08034345 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-11 [patent_title] => 'Anti-PCI antibody for regulating liver regeneration/repair' [patent_app_type] => utility [patent_app_number] => 11/577157 [patent_app_country] => US [patent_app_date] => 2005-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 22296 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/034/08034345.pdf [firstpage_image] =>[orig_patent_app_number] => 11577157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5694172 [patent_doc_number] => 20060154319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Inhibition of bradykinin release' [patent_app_type] => utility [patent_app_number] => 11/248110 [patent_app_country] => US [patent_app_date] => 2005-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16601 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20060154319.pdf [firstpage_image] =>[orig_patent_app_number] => 11248110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7773727 [patent_doc_number] => 08119406 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-21 [patent_title] => 'System and method for production of antibodies in plant cell culture' [patent_app_type] => utility [patent_app_number] => 11/665344 [patent_app_country] => US [patent_app_date] => 2005-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 22 [patent_no_of_words] => 19880 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/119/08119406.pdf [firstpage_image] =>[orig_patent_app_number] => 11665344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4516265 [patent_doc_number] => 07932363 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-26 [patent_title] => 'Antibody that binds human eosinophil-derived basic protein' [patent_app_type] => utility [patent_app_number] => 11/200125 [patent_app_country] => US [patent_app_date] => 2005-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18600 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/932/07932363.pdf [firstpage_image] =>[orig_patent_app_number] => 11200125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5828910 [patent_doc_number] => 20060063713 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Methods for restoring immune balance for the treatment of T-cell mediated diseases' [patent_app_type] => utility [patent_app_number] => 11/219339 [patent_app_country] => US [patent_app_date] => 2005-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11123 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20060063713.pdf [firstpage_image] =>[orig_patent_app_number] => 11219339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5747459 [patent_doc_number] => 20060110390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Inhibition of Ku as a treatment for cardiovascular diseases' [patent_app_type] => utility [patent_app_number] => 11/203828 [patent_app_country] => US [patent_app_date] => 2005-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 35446 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20060110390.pdf [firstpage_image] =>[orig_patent_app_number] => 11203828 [rel_patent_id] =>[rel_patent_doc_number] =>)